國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Bayesian applications in pharmaceuti...

Lakshminarayanan, Mani.

Bayesian applications in pharmaceutical development

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Bayesian applications in pharmaceutical developmentedited by Mani Lakshminarayanan, Fanni Natanegara.
其他作者:	Lakshminarayanan, Mani.
出版者:	Boca Raton :CRC Press,c2020.
面頁冊數:	1 online resource (1 v.)
附註:	"A Chapman & Hall book"--title page.
標題:	Drug developmentStatistical methods.
電子資源:	https://www.taylorfrancis.com/books/9781315099798
ISBN:	9781315099798$q(electronic bk.)

Bayesian applications in pharmaceutical development
Bayesian applications in pharmaceutical development[electronic resource] /edited by Mani Lakshminarayanan, Fanni Natanegara. - 1st ed. - Boca Raton :CRC Press,c2020. - 1 online resource (1 v.) - Chapman & Hall/CRC biostatistics series. - Chapman & Hall/CRC biostatistics series..

"A Chapman & Hall book"--title page.

The cost for bringing new medicine from discovery to market has nearly doubled in the last decade and has now reached

ISBN: 9781315099798$q(electronic bk.)Subjects--Topical Terms:

181868
Drug development
--Statistical methods.

LC Class. No.: RM301.25

Dewey Class. No.: 615.1901519542

Bayesian applications in pharmaceutical development
LDR:03365cmm a2200361 a 4500 001 605918
003 FlBoTFG
005 20191209011532.0
006 m o d
007 cr cnu---unuuu
008 211203s2020 flu o 000 0 eng d
020 $a 9781315099798$q(electronic bk.)
020 $a 1315099799$q(electronic bk.)
020 $a 9781351584173$q(electronic bk. ;$qPDF)
020 $a 1351584170$q(electronic bk. ;$qPDF)
020 $a 9781351584166$q(electronic bk. ;$qEPUB)
020 $a 1351584162$q(electronic bk. ;$qEPUB)
020 $a 9781351584159$q(electronic bk. ;$qMobipocket)
020 $a 1351584154$q(electronic bk. ;$qMobipocket)
020 $z 9781138296763
020 $z 1138296767
035 $a 9781315099798
040 $a OCoLC-P $b eng $c OCoLC-P
050 4 $a RM301.25
082 0 4 $a 615.1901519542 $2 23
245 0 0 $a Bayesian applications in pharmaceutical development $h [electronic resource] / $c edited by Mani Lakshminarayanan, Fanni Natanegara.
250 $a 1st ed.
260 $a Boca Raton : $b CRC Press, $c c2020.
300 $a 1 online resource (1 v.)
490 1 $a Chapman & Hall/CRC biostatistics series
500 $a "A Chapman & Hall book"--title page.
520 $a The cost for bringing new medicine from discovery to market has nearly doubled in the last decade and has now reached $2 .6 billion. There is an urgent need to make drug development less time-consuming and less costly. Innovative trial designs/ analyses such as the Bayesian approach are essential to meet this need. This book will be the first to provide comprehensive coverage of Bayesian applications across the span of drug development, from discovery, to clinical trial, to manufacturing with practical examples. This book will have a wide appeal to statisticians, scientists, and physicians working in drug development who are motivated to accelerate and streamline the drug development process, as well as students who aspire to work in this field. The advantages of this book are: Provides motivating, worked, practical case examples with easy to grasp models, technical details, and computational codes to run the analyses Balances practical examples with best practices on trial simulation and reporting, as well as regulatory perspectives Chapters written by authors who are individual contributors in their respective topics Dr. Mani Lakshminarayanan is a researcher and statistical consultant with more than 30 years of experience in the pharmaceutical industry. He has published over 50 articles, technical reports, and book chapters besides serving as a referee for several journals. He has a PhD in Statistics from Southern Methodist University, Dallas, Texas and is a Fellow of the American Statistical Association. Dr. Fanni Natanegara has over 15 years of pharmaceutical experience and is currently Principal Research Scientist and Group Leader for the Early Phase Neuroscience Statistics team at Eli Lilly and Company. She played a key role in the Advanced Analytics team to provide Bayesian education and statistical consultation at Eli Lilly. Dr. Natanegara is the chair of the cross industry-regulatory-academic DIA BSWG to ensure that Bayesian methods are appropriately utilized for design and analysis throughout the drug-development process.
588 $a Description based on print version record.
650 0 $a Drug development $x Statistical methods. $3 181868
650 0 $a Bayesian statistical decision theory. $3 182005
700 1 $a Lakshminarayanan, Mani. $3 902437
700 1 $a Natanegara, Fanni. $3 902438
830 0 $a Chapman & Hall/CRC biostatistics series. $3 508409
856 4 0 $u https://www.taylorfrancis.com/books/9781315099798